Avidity Biosciences Inc RNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:22 PM EST
25.00quote price arrow up+0.87 (+3.61%)
Volume
1,558
Close
24.13quote price arrow down-1.28 (-5.04%)
Volume
742,537
52 week range
21.70 - 37.46

...

Loading . . .

KEY STATS

  • Open25.62
  • Day High26.71
  • Day Low23.81
  • Prev Close25.41
  • 52 Week High37.46
  • 52 Week High Date09/15/20
  • 52 Week Low21.70
  • 52 Week Low Date02/18/21
  • Market Cap905.60M
  • Shares Out37.53M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.86
  • P/E (TTM)-27.91
  • Fwd P/E (NTM)-15.67
  • EBITDA (MRQ)-27.416M
  • ROE (MRQ)-
  • Revenue (MRQ)4.99M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-675.01%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Avidity Biosciences Inc News

There is no recent news for this security.

Latest RNA News From Our Partners

QUOTE FINDER

Profile

MORE
Avidity Biosciences, Inc. is a biopharmaceutical company. The Company focuses on oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC), designed to overcome the limitations of oligonucleotide-based therapies to treat a range of serious diseases. It utilizes its AOC platform to design, engineer and develop therapeutics that combine the tissue selectivity of monoclonal antibodies (mAbs) and the precision of oligonucleotide-based therapies. The...
Troy Wilson J.D., Ph.D.
Chairman
Sarah Boyce
President
Joseph Baroldi
Chief Operating Officer
Michael Maclean
Chief Financial Officer
Vanessa Jacoby CPA
Vice President - Finance
Address
10975 N. TORREY PINES RD.,, #150
La Jolla, CA
92037
United States